Get Real Time Here
| Open6.800 | Close6.660 |
| Vol / Avg.438.656K / 523.967K | Mkt Cap409.080M |
| Day Range6.450 - 6.910 | 52 Wk Range3.260 - 14.044 |
Terns Pharma Stock (NASDAQ:TERN), Quotes and News Summary
Terns Pharma Stock (NASDAQ: TERN) stock price, news, charts, stock research, profile.
| Open6.800 | Close6.660 |
| Vol / Avg.438.656K / 523.967K | Mkt Cap409.080M |
| Day Range6.450 - 6.910 | 52 Wk Range3.260 - 14.044 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.300 | -0.420 | -0.1200 | ||||
| REV | 0 |
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.340 | -0.250 | 0.0900 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-12-05 | JMP Securities | Silvan Tuerkcan | Reiterates | Market OutperformMarket Outperform | Maintains | - | 17.00 |
| 2023-11-27 | Mizuho | Graig Suvannavejh | Maintains | BuyBuy | Lowers | 17.00 | 10.00 |
| 2023-08-10 | HC Wainwright & Co. | Ed Arce | Maintains | NeutralNeutral | Lowers | 11.00 | 8.00 |
| 2023-08-09 | JP Morgan | Eric Joseph | Maintains | NeutralNeutral | Raises | 10.00 | 11.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| TERN | Terns Pharma | -2.79% | 409.1M |
| AVIR | Atea Pharmaceuticals | 2.04% | 250.3M |
| TBPH | Theravance Biopharma | 1.23% | 534.3M |
| THRD | Third Harmonic Bio | 2.01% | 388.7M |
| GHRS | GH Research | 9% | 340.2M |
How do I buy Terns Pharma (TERN) stock?
You can purchase shares of Terns Pharma (NASDAQ: TERN) through any online brokerage.
Who are Terns Pharma's (TERN) competitors?
Other companies in Terns Pharma’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
What is the target price for Terns Pharma (TERN) stock?
The latest price target for Terns Pharma (NASDAQ: TERN) was reported by JMP Securities on Tuesday, December 5, 2023. The analyst firm set a price target for 17.00 expecting TERN to rise to within 12 months (a possible 156.80% upside). 24 analyst firms have reported ratings in the last year.
Current Stock Price for Terns Pharma (TERN)?
The stock price for Terns Pharma (NASDAQ: TERN) is $6.62 last updated December 8, 2023 at 9:46 PM UTC.
Does Terns Pharma (TERN) pay a dividend?
There is no dividend information for Terns Pharma.
When is Terns Pharma (NASDAQ:TERN) reporting earnings?
Terns Pharma’s Q3 earnings are confirmed for Tuesday, November 14, 2023.
Is Terns Pharma (TERN) going to split?
There is no upcoming split for Terns Pharma.
What sector and industry does Terns Pharma (TERN) operate in?
Terns Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.